BDR-WM TRIAL

This home page is related to the ongoing EMN sponsored trial:

A Phase II Study of Combination Bortezomib, Dexamethasone, and Rituximab (BDR) in previously untreated Patients with Waldenstrom's Macroglobulinemia: A multicenter Trial of the European Myeloma Network (EMN).

News

Trial status

During the summer Italy and Denmark has opened for inclusions into the trial, coordinated by Professor Giovanni Palladini and Professor Hans E Johnsen.

21 Sep 2009 by BDR-WM Trial

Presentation by Professor Meletios A. Dimopoulos online

At the International MW meeing in Washington Professor Meletios A. Dimopoulos from Athen gave an overview of "Novel Treatment Options".

Find the slide show here

21 Sep 2009 by BDR-WM Trial

BDR WM Trial

The BDR-WM trial has now enrolled more than 30 patients.
Please find the presenation from Professor Dimopoulos given at the March 2009 meeting i Washington.
See the presentation
Here

25 May 2009 by BDR-WM Trial

Minutes from the teleconference 20/11/2007 online

Please finde the minutes from the teleconference 20/11/2007 at the intranet part of this web page. Click at the 'log in' link in the left navigation menu.

19 Dec 2007 by BDR-WM Trial

The BDR WM trial web page is online

The home page is related to the ongoing EMN sponsored trial:

A Phase II Study of Combination Bortezomib, Dexamethasone, and Rituximab (BDR) in previously untreated Patients with Waldenstrom's Macroglobulinemia: A multicenter Trial of the European Myeloma Network (EMN).

21 Sep 2007 by BDR-WM Trial

Publications about WM

Pub 1:
WM, Am. J. Hematology, 2003

Pub 2:
WM, Blood, 2007

Pub 3:
WM, Lancet Oncol., 2003

Pub 4:
WM, Clin Lymphoma Meyloma, 2006

Pub 5:
WM, Br J Haematol, 2007

Slides

Slide 1:
Phase II Study of Combination Bortezomib Dexamethasone

BDR-WM TRIAL
Last Update: 21st September 2007